미국의 자기공명영상(MRI) 시스템 시장 규모는 2023년 18억 3,000만 달러에서 2031년에 27억 8,000만 달러에 달할 것으로 예측되며, 예측 기간인 2024-2031년에 CAGR로 5.38%의 성장이 전망됩니다.
MRI 시스템 시장은 주로 미국의 급속한 발전과 기술 혁신에 적합한 의료 인프라로 인해 미국에서 우위를 점할 것으로 예상되며, MRI 기술의 발전으로 미국뿐만 아니라 전 세계에서 MRI 시스템 시장의 혁신이 가속화되고 있습니다. 이미지 품질과 진단 정확도의 새로운 발전에는 다중 파라메트릭 이미징, 고자장 MRI 스캐너, AI를 활용한 이미지 분석 등이 포함됩니다. 또한 확산텐서영상(DTI)과 기능적 자기공명영상(fMRI)의 결합은 뇌 기능과 연결성을 연구하는 새로운 수단을 제공함으로써 신경질환의 진단과 치료를 개선하고 있습니다. 이처럼 신경질환에 취약한 노인 인구 증가와 DTI와 fMRI 기술의 발전이 결합하여 MRI 시스템 시장의 성장을 더욱 촉진할 것으로 예상됩니다.
또한 휴대용 및 소형 MRI 시스템의 발전으로 원격지에서의 접근성과 활용성이 향상되고 있으며, Fujifilm Holdings Corporation과 같은 세계 선도기업과 Hyperfine, Inc. 42, Inc.와 같은 신흥 시장 기업은 소형 MRI 시스템 개발에 지속적으로 집중하고 있습니다. 따라서 기술 발전과 신제품 출시는 미국 MRI 시스템 시장의 성장을 가속할 것입니다. 예를 들어 neuro42, Inc.는 2024년 2월 미국 FDA의 510(k) 허가를 획득한 신경영상용 휴대용 진단용 MRI 스캐너를 출시했습니다. 이 회사는 이 시스템을 2024년 중 미국 시장에 출시할 예정입니다.
MRI에 대한 인식 개선으로 시장 성장 촉진
미국 자기공명영상(MRI) 시스템 시장은 MRI 장비 설치 증가로 인해 성장하고 있습니다. 고령화, 만성질환 증가, 정확하고 시기적절한 진단의 필요성 등으로 인해 첨단 영상진단에 대한 수요가 증가함에 따라 의료시설은 MRI 기술에 많은 투자를 하고 있습니다. 스캔 시간 단축, 이미지의 고해상도화 등 최신 MRI 장비의 업그레이드된 기능은 의료 시설과 진단센터를 구식 기술에서 벗어나게 하는 요인으로 작용하고 있습니다. 이러한 발전으로 인해 MRI 서비스는 보다 광범위하게 이용 가능하고 합리적인 가격으로 제공되어 보다 광범위한 질병을 치료하고 환자 치료 결과를 개선하는 데 기여하고 있습니다. 또한 비침습적 진단 방법에 대한 수요 증가와 질병의 조기 진단에 있으며, MRI의 장점에 대한 지식이 증가함에 따라 MRI 시스템 시장이 확대되고 있습니다. 예를 들어 2023년 4월 MDPI(Multidisciplinary Digital Publishing Institute) 저널에 게재된 남가주대학교 연구진의 연구에 따르면 외래 환자에서 많은 영상 진단 방법이 지연되는 것으로 나타났습니다. MRI, MRI, CT의 경우 12,000건 이상의 영상진단 지연이 발생하여 가장 큰 감소를 보였으며, MRI 서비스의 급격한 감소로 인해 COVID-19 팬데믹은 시장에 큰 영향을 미쳤고, 그 이후에도 계속 성장세를 보이고 있습니다.
노년층 인구 증가로 시장 성장 촉진
미국 MRI 시스템 시장의 주요 성장 촉진요인 중 하나는 고령화입니다. 노인 인구가 증가함에 따라 신경 질환, 관절 질환, 심혈관 질환 등 노화 관련 건강 문제의 유병률이 증가하고 있습니다. 종합적이고 비침습적인 영상 진단이 가능한 MRI 기술은 많은 복잡한 질환의 진단과 치료에 필수적인 툴입니다. 노년층은 만성질환을 앓기 쉽고 지속적인 관리가 필요하므로 잦은 영상 진단이 필요할 가능성이 높습니다. 따라서 고령화가 진행됨에 따라 첨단 진단 장비에 대한 수요가 증가하고 있으며, 이는 미국 MRI 시스템 시장의 성장을 가속하고 있습니다. 미국의 65세 이상 인구 비중은 2022년 17%에서 2050년 23%로 증가할 것으로 예상됩니다. 또한 65세 이상 노인 인구는 2022년 5,000만 명에서 2050년 8,200만 명으로 47% 증가할 것으로 예상됩니다.
미국의 자기공명영상(MRI) 시스템 시장에 대해 조사분석했으며, 시장 규모와 예측, 시장 역학, 주요 기업의 상황과 전망 등을 제공하고 있습니다.
United States magnetic resonance imaging (MRI) systems market is projected to witness a CAGR of 5.38% during the forecast period 2024-2031, growing from USD 1.83 billion in 2023 to USD 2.78 billion in 2031.
The MRI systems market is expected to dominate in the United States mainly because of its fast-paced development and innovation-friendly healthcare infrastructure. Innovation in the MRI systems market has accelerated in the United States as well as globally due to advancements in MRI technologies. New advancements in image quality and diagnostic precision include multi-parametric imaging, higher-field MRI scanners, and AI-driven image analysis. In addition, new avenues for studying brain function and connectivity have been made possible by the combination of diffusion tensor imaging (DTI) and functional magnetic resonance imaging (fMRI), which has improved neurological disease diagnosis and treatment. Thus, the rising geriatric population, which is more prone to developing neurological disorders coupled with advancements in DTI and fMRI technologies, is expected further to fuel the growth of MRI systems in the market.
Furthermore, advancements in portable and compact MRI systems have improved the access and availability of these systems in remote areas. Global leaders, such as Fujifilm Holdings Corporation, and emerging market players, such as Hyperfine, Inc., and neuro42, Inc., continuously focus on developing compact MRI systems. Thus, technological advancements and new product launches will accelerate the growth of the United States MRI systems market. For instance, in February 2024, neuro42, Inc. received US FDA 510(k) clearance for its portable diagnostic MRI scanner for neuroimaging applications. The company is planning to launch this system in the US market during year 2024.
Rising Awareness About MRIs Drive Market Growth
The magnetic resonance imaging (MRI) systems market in the United States is expanding due to the growing installation of MRI machines. Healthcare facilities are heavily investing in MRI technology as demand for advanced diagnostic imaging is rising due to an aging population, an increase in chronic diseases, and the need for accurate and timely diagnosis. The upgraded features of contemporary MRI machines, such as faster scanning periods and higher resolution images, are drawing medical facilities and diagnostic centers to replace their outdated technology. These developments make MRI services more widely available and reasonably priced, treating a wider spectrum of illnesses and enhancing patient outcomes. In addition, the MRI systems market is expanding due to rising demand for non-invasive diagnostic methods and growing knowledge of the advantages of MRI in early disease diagnosis. For example, a study conducted in April 2023 and published in the Multidisciplinary Digital Publishing Institute (MDPI) journal by researchers at the University of Southern California found that delays were observed in many imaging modalities in the outpatient setting, with the modalities of mammography, MRI, and CT showing the largest decreases with over 12,000 imaging delays. Due to the sharp decline in MRI services, the COVID-19 pandemic thus had a major effect on the market and has only flourished ever since then.
Rising Geriatric Population Boosts Market Growth
One major factor propelling the growth of the MRI systems market in the United States is the aging population. The prevalence of age-related health concerns, including neurological illnesses, joint problems, and cardiovascular conditions, is rising along with the elderly population. With its comprehensive and non-invasive imaging capabilities, MRI technology is a vital tool in the diagnosis and treatment of many intricate disorders. Since they are more likely to have chronic illnesses and need ongoing care, older persons are more likely to need frequent diagnostic imaging. Thus, in turn, the aging population is driving an increased demand for advanced diagnostic instruments, which is driving the growth of the MRI systems market in the United States. The population share of the United States, which constitutes people aged 65 and above, is projected to rise from 17% in 2022 to 23% by 2050. Moreover, the number of people aged 65 and above is expected to rise from 50 million in 2022 to 82 million in 2050, showcasing a hike of 47%.
Dominance of High Field Strength MRI Segment in the United State MRI Systems Market
The magnetic resonance imaging (MRI) systems market in the United States is expanding at a substantial rate due to the introduction of high-field strength (HF) and ultra-high field strength (UH) MRI systems. Compared to conventional 1.5T MRI machines, HF MRI systems, which commonly operate at 3 Tesla (T), and UH MRI systems, which operate at 7T and beyond, offer improved imaging capabilities. These cutting-edge devices enable earlier and more accurate diagnosis of a variety of illnesses by improving image contrast, resolution, and detail. Since high-field strength MRI systems can record fine anatomical and physiological features, which are essential for diagnosing complicated neurological, musculoskeletal, and cardiovascular problems, they are gaining increasing traction and widespread adoption. For instance, in March 2024, Siemens Healthineers AG announced the launch of MAGNETOM Terra.X. This second-generation clinical 7-tesla magnetic resonance imaging scanner significantly improves 7T MR scanning capabilities with new hardware and XA60A software, which has also received FDA certification. The MAGNETOM Terra, which made its debut in 2017 as the first 7T clinical MR scanner in the world and allowed incredibly high-resolution imaging, is now replaced by the MAGNETOM Terra.X.
Neurology Segment Dominates United States Magnetic Resonance Imaging (MRI) Systems Market
MRI systems are utilized to obtain fine-grained images of the bones, organs, tissues, and nerves in the body. MRI is used to diagnose several conditions, including stroke, traumatic brain injury, brain and spinal cord tumors, inflammation, infection, vascular abnormalities, brain damage connected to epilepsy, abnormally formed brain regions, and other neurodegenerative illnesses. Due to the growing use of MRI imaging in the diagnosis of neurological diseases and the development of sophisticated MRI equipment for neurology, the neurology segment of the market is anticipated to rise significantly. Additionally, it is anticipated that the rise in neurological conditions like dementia and Alzheimer's disease will increase demand for MRI machines in the US, which will support the market's expansion throughout the projected period. For instance, the Alzheimer's Disease Facts and Figures study estimated that 6.7 million Americans, 65 years of age and older, were diagnosed with Alzheimer's dementia in 2023. Furthermore, it is anticipated that by 2050, 12.7 million of the population would be suffering from dementia in the United States.
Future Market Scenario (2024-2031F)
The main factors contributing to the anticipated growth of the United States magnetic resonance imaging (MRI) systems market are the rising numbers of chronic ailments, the increasing prevalence of diseases, and thus, the rising requirement to conduct diagnostic tests. However, the growing need to have precision medicine to maintain a healthy population is also going to fuel the MRI Systems market growth in the future. Given that technology is advancing, cutting-edge technology in the area is expected. Players in this market are expanding at an unparalleled rate, introducing cost-effective and efficient technologies. For instance, in October 2023, Koninklijke Philips N.V. announced its collaboration with Quibim to introduce advanced AI-driven imaging software aimed at prostate cancer detection. By combining Philips' innovative AI-enhanced MR imaging software with Quibim's AI-powered image analysis software, healthcare providers can expedite and simplify prostate cancer diagnosis and care.
Key Players Landscape and Outlook
The United States MRI systems market is a consolidated market with the majority of the share held by global leaders, including GE Healthcare Technologies Inc., Siemens Healthineers AG, Koninklijke Philips N.V., Fujifilm Holdings Corporation, and Canon Inc. These players are complying with new strategic initiatives regarding the launches of newly developed magnetic resonance imaging techniques to help researchers and to strengthen their presence in the market. New product launches, agreements based on contracts, acquisitions and mergers, investments, and partnerships are a few ways through which they are trying to achieve the same.
For example, in September 2023, an agreement in the field of MRI was signed by Subtle Medical, Inc., an artificial intelligence (AI)-powered image acquisition solution provider, and Bracco Imaging S.p.A., a manufacturer of diagnostic imaging components. These international collaborations were anticipated to start in the United States, where Bracco Imaging most likely uses Bracco Diagnostics Inc., a subsidiary, to distribute its line of goods and services.
All segments will be provided for all regions and countries covered
Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work.